ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
132.14 EUR
+3.7 (+2.88%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 20 industry peers in the Life Sciences Tools & Services industry. ILU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILU has a decent growth rate and is not valued too expensively. This makes ILU very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year ILU was profitable.
- In the past year ILU had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
- ILU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ILU's Return On Assets of 11.38% is amongst the best of the industry. ILU outperforms 95.00% of its industry peers.
- ILU's Return On Equity of 29.53% is amongst the best of the industry. ILU outperforms 100.00% of its industry peers.
- ILU has a Return On Invested Capital of 14.61%. This is amongst the best in the industry. ILU outperforms 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 16.39%, ILU belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
- ILU has a Operating Margin of 20.41%. This is amongst the best in the industry. ILU outperforms 90.00% of its industry peers.
- ILU's Operating Margin has declined in the last couple of years.
- The Gross Margin of ILU (66.74%) is better than 100.00% of its industry peers.
- ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILU is still creating some value.
- Compared to 1 year ago, ILU has about the same amount of shares outstanding.
- The number of shares outstanding for ILU has been increased compared to 5 years ago.
- Compared to 1 year ago, ILU has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.80 indicates that ILU is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.80, ILU belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
- The Debt to FCF ratio of ILU is 1.99, which is an excellent value as it means it would take ILU, only 1.99 years of fcf income to pay off all of its debts.
- ILU's Debt to FCF ratio of 1.99 is amongst the best of the industry. ILU outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
- ILU has a better Debt to Equity ratio (0.42) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.8 |
ROIC/WACC1.34
WACC10.87%
2.3 Liquidity
- A Current Ratio of 1.43 indicates that ILU should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.43, ILU perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
- ILU has a better Quick ratio (1.12) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 152.02% over the past year.
- Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
- ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
- Measured over the past years, ILU shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
- The Earnings Per Share is expected to grow by 24.95% on average over the next years. This is a very strong growth
- Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 3.99% on average per year.
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 35.62, the valuation of ILU can be described as expensive.
- ILU's Price/Earnings ratio is a bit more expensive when compared to the industry. ILU is more expensive than 65.00% of the companies in the same industry.
- ILU's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.32.
- Based on the Price/Forward Earnings ratio of 30.27, the valuation of ILU can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU indicates a slightly more expensive valuation: ILU is more expensive than 65.00% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of ILU to the average of the S&P500 Index (24.32), we can say ILU is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.62 | ||
| Fwd PE | 30.27 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ILU.
- 80.00% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.7 | ||
| EV/EBITDA | 20.46 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ILU has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as ILU's earnings are expected to grow with 34.05% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y44.64%
EPS Next 3Y34.05%
5. Dividend
5.1 Amount
- ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (1/22/2026, 7:00:00 PM)
132.14
+3.7 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap20.19B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts73.33
Price Target111.36 (-15.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)5.42%
PT rev (3m)13.87%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.62 | ||
| Fwd PE | 30.27 | ||
| P/S | 5.53 | ||
| P/FCF | 23.7 | ||
| P/OCF | 21.12 | ||
| P/B | 9.95 | ||
| P/tB | 22.73 | ||
| EV/EBITDA | 20.46 |
EPS(TTM)3.71
EY2.81%
EPS(NY)4.37
Fwd EY3.3%
FCF(TTM)5.58
FCFY4.22%
OCF(TTM)6.26
OCFY4.73%
SpS23.91
BVpS13.27
TBVpS5.81
PEG (NY)0.37
PEG (5Y)N/A
Graham Number33.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.8 |
F-Score7
WACC10.87%
ROIC/WACC1.34
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year36.79%
EBIT Next 3Y17.14%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status for ILU stock?
ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for ILU stock?
The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.